- Home
- General Medicine
- Highlights of the Phase 2b Randomized Trial of Oral PCSK9 Inhibitor Enlicitide Chloride in Adults with Hypercholesterolemia

1w3 min read
Medical Article
Introduction Hypercholesterolemia, particularly elevated low-density lipoprotein cholesterol (LDL-C), plays a key role in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) (1). Despite widespread use of statins, a substantial proportion of patients remain unable to attain optimal LDL-C levels, often due to statin intolerance, inade

Highlights of the Phase 2b Randomized Trial of Oral PCSK9 Inhibitor Enlicitide Chloride in Adults with Hypercholesterolemia
15 Reached
Similar Content

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes